ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,218.94
0.09%
US Tech 100
17,660.40
0.11%
다우존스 지수
39,496.22
0.28%
Bitcoin
61,028.26
-3.20%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. ImmunoPrecise Antibodies Ltd (IPA)

  7. ImmunoPrecise Antibodies Ltd (IPA) 뉴스

IPA ImmunoPrecise Antibodies Ltd

1.30
0.04 (3.17%)
최종 업데이트: 01:34:00
15분 지연
기업명 주식 심볼 시장 주식 타입
ImmunoPrecise Antibodies Ltd IPA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.04 3.17% 1.30 01:34:00
개장가 저가 고가 종가 전일 종가
1.25 1.24 1.30 1.26
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/03/202403:35BWInterSystems et BioStrand, filiale d’IPA, collaborent au..
28/03/202420:02BWInterSystems and IPA’s Subsidiary BioStrand Collaborate to..
21/03/202402:52BWIPA acquiert l'instrument Carterra LSA® pour améliorer la..
20/03/202420:02BWIPA Acquires the Carterra LSA® Instrument to Enhance..
15/03/202408:39BWIPA présente ses résultats financiers et les récents points..
14/03/202421:05BWIPA Reports Financial Results and Recent Business Highlights..
08/03/202405:24BWBioStrand, filiale d'IPA, annonce une avancée majeure dans..
08/03/202401:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/03/202421:02BWIPA’s subsidiary BioStrand Unveils Major Breakthrough in..
05/03/202406:50BWL'IPA publiera ses résultats financiers et les faits..
04/03/202422:01BWIPA to Report Financial Results and Recent Business..
24/02/202407:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/02/202407:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/02/202405:12EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
11/01/202403:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/01/202403:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/12/202305:08BWIPA présente ses résultats financiers et les récents points..
14/12/202322:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202322:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202322:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202322:01BWIPA Reports Financial Results and Recent Business Highlights..
09/12/202311:57BWIPA annonce la clôture d'une offre publique d'actions..
09/12/202307:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/12/202307:00BWIPA Announces Closing of $1.265 Million Public Offering of..
08/12/202306:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/12/202307:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202321:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202321:00BWIPA annonce le prix des actions ordinaires de son émission..
06/12/202320:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202310:22BWIPA annonce une proposition d'offre publique d'actions..
06/12/202306:35BWIPA Announces Proposed Public Offering of Common Shares
06/12/202306:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/11/202303:09BWImmunoPrecise Antibodies Ltd annonce des nominations clés au..
27/11/202322:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202322:01BWImmunoPrecise Antibodies Ltd. Announces Key Board and Board..
17/11/202307:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202304:09BWBioStrand® dévoile une approche révolutionnaire de la..
13/11/202322:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202322:32BWBioStrand® Unveils a Revolutionary Approach to Biological..
26/10/202301:12BWBioStrand, filiale de l'IPA, fait le point sur LENSai™
25/10/202321:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202321:01BWIPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
24/10/202302:36BWIPA apporte une mise à jour sur sa stratégie de croissance..
23/10/202321:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/10/202321:01BWIPA Provides Update on Growth Strategy and Recent Share..
21/10/202303:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/09/202300:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/09/202305:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/09/202301:34BWImmunoPrecise Antibodies annonce le remplacement de son..
19/09/202321:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

최근 히스토리

NASDAQ
IPA
ImmunoPrecise Antibodies
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유